FTSE 100 to end 2021 at 7,200 points? Why I think UK shares could be too cheap to miss!

Is the FTSE 100 about to balloon in value? Royston Wild explains why now’s a great time for UK share investors to go shopping for blue-chip bargains.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

The Covid-19 crisis has largely been a catastrophe for UK share prices in 2020. The FTSE 100 has taken an almighty walloping and, at 6,650 points as of right now, is down 12% from 1 January.

Hopes are rising though, that we could be on the cusp of a new bull market. With a no-deal Brexit catastrophe averted and a coronavirus vaccine breakthrough there’s huge optimism that the FTSE 100 could roar back and give us all some good news in 2021.

The experts at UBS are certainly expecting the FTSE 100 to rocket from current levels. They reckon Britain’s blue-chip share index to trade at around 7,200 points on 31 December, 2021. This is built on expectations that average annual earnings will rocket 21% next year and rise an extra 10% in 2022.

This leaves the FTSE 100 dealing on an undemanding forward price-to-earnings (P/E) ratio of 16 times. The UK share index carries an average 3.9% dividend yield too which, in my opinion, isn’t to be sniffed at.

Image of person checking their shares portfolio on mobile phone and computer

FTSE 100 = top value!

UBS reckons the FTSE 100 offers terrific value for investors heading into the new year too. The bank notes that “the UK equity market has been one of the worst-performing major global markets since the Brexit referendum in June 2016,” and, as a consequence, “valuations for UK equities relative to Europe [are] close to 20-year lows.”

The FTSE 100 has also greatly underperformed other major global equity markets in recent months. It’s soared today following the recent passing of fresh stimulus measures in the US and by the thin Brexit deal. But its performance in recent weeks is still pretty tame compared to that of the Dow Jones. The US index has hit repeated highs and struck new peaks overnight. Japan’s Nikkei has also touched fresh 30-year peaks in recent hours.

2 cheap UK shares on my watchlist

I believe the FTSE 100 offers unmissable value at current levels. It was already looking undervalued prior to 2020. And the stock market crash of late February and early March leaves plenty of top UK shares trading at prices I consider too cheap to miss.

Take GlaxoSmithKline for example. The pharmaceuticals giant doesn’t just trade on a cheap P/E ratio of 12 times for 2021. It carries a monster 6% dividend yield too. Legal & General offers even better value. The life insurer trades on an earnings multiple of 10 times and carries a huge 7.3% dividend yield. The list of blue-chip bargains is huge.

Investors need to be careful before taking the plunge. Some FTSE 100 shares (like Lloyds) deserve to have slumped in value in 2020 as Covid-19 has significantly damaged their earnings opportunities.

Many UK shares also have high debt levels that they may struggle to service in 2021 and beyond. But experts like The Motley Fool can help you avoid these duds and make a lot of money next year and beyond.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline and Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »